Gene that predisposes people to syndrome with high cancer risk identified
December 22nd, 2010 - 5:35 pm ICT by ANIWashington, Dec 22 (ANI): Scientists have discovered a new genetic alteration that predisposes people to Cowden syndrome, a rare disorder that is characterized by high risks of breast, thyroid and other cancers.
Patients with Cowden syndrome and Cowden-like syndrome have mutations in the tumour suppressor PTEN gene.
These mutations are associated with increased risk of various malignancies, approximately 10 percent lifetime risk for thyroid cancer, and as much as 50 percent lifetime risk for female breast cancer over the general population, according to background information in the article.
Other mechanisms of loss of function could result in under expression of PTEN or of KILLIN, a novel tumour suppressor gene lying right next to PTEN, which may account for the remainder of Cowden syndrome and Cowden-like syndrome.
“In the context of a difficult-to-recognize syndrome, identification of additional cancer predisposition genes would facilitate molecular diagnosis, genotype-specific predictive testing of family members who are as yet clinically unaffected, genetic counselling, and medical management,” the authors wrote.
They analyzed nucleic acids in 123 patients with Cowden syndrome or Cowden-like syndrome and 50 unaffected subjects without PTEN variants for germline methylation and expression of PTEN or KILLIN from August 2008 to June 2010.
They found that KILLIN was a predisposition gene for Cowden syndrome and Cowden-like syndrome.
“By discovering another cancer predisposition gene, we have added to the sensitivity of molecular diagnosis and predictive testing becomes possible. Importantly, genetic counseling and gene-informed risk assessment and management become evidence based,” the researchers wrote.
“If our observations of 2- to 3-fold increased risks of renal and/or breast cancer with KILLIN germline methylation over those of PTEN mutation holds, then extra vigilance for the organs at risk, breast and kidneys, is warranted. The KILLIN-associated breast cancer risks would parallel those conferred by germline BRCAl/2 mutations,” they added.
The preliminary research is published in the December 22/29 issue of the Journal of the American Medical Association. (ANI)
- Genetic predisposition for breast, kidney cancers discovered - Dec 23, 2010
- Scientists bring cancer cells back under normal control - Jan 19, 2011
- Lynch syndrome's mutated genes raise risk of cancers - Feb 15, 2012
- Preventive mastectomies pay off for some women - Sep 04, 2010
- Walnuts reduce breast cancer risk - Sep 02, 2011
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- How broccoli cuts prostate cancer risk - Jul 13, 2010
- Study finds new risk factor for developing breast cancer - Nov 11, 2010
- Genetic variants that modify breast cancer risk identified - Sep 20, 2010
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- Breast cancer in young women 'ups risk of disease in relatives' - Sep 30, 2010
- Vitamin D protects obese women against endometrial cancer - Sep 22, 2010
- Genetic variants may affect breast cancer risk in women with BRCA2 mutations - Oct 29, 2010
- New technique diagnoses brain cancers non-invasively - Jan 29, 2012
- Breast cancer risk 'can be assessed by examining breast milk' - Apr 05, 2011
Tags: breast cancer, cancer predisposition, cancer risk, female breast cancer, genetic alteration, genetic counseling, genetic counselling, lifetime risk, malignancies, medical management, methylation, molecular diagnosis, nucleic acids, pten, rare disorder, risk assessment, suppressor gene, thyroid cancer, tumour suppressor, vigilance